Recent Developments in the Management of Patients at Risk for Sudden Cardiac Death

References

• . National Institute for Health and Clinical Excellence. Implantable cardioverter defibrillators for arrhythmias www.nice.org.uk/TA095. 2006:1–33. Accessed February 7, 2011
   Google Scholar
• . Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J. 1987;113(6):799–804
   PubMed Web of Science ®Google Scholar
• . Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol. 1987;60(10):801–806
   PubMed Web of Science ®Google Scholar
• . Behr E, Wood DA, Wright M, . Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet. 2003;362(9394):1457–1459
   PubMed Web of Science ®Google Scholar
• . Tung RT, Shen WK, Hammill SC, Gersh BJ. Idiopathic ventricular fibrillation in out-of-hospital cardiac arrest survivors. Pacing Clin Electrophysiol. 1994;17(8):1405–1412
   PubMed Web of Science ®Google Scholar
• . Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am Heart J. 1990;120(3):661–671
   PubMed Web of Science ®Google Scholar
• . Donohue D, Tehrani F, Jamehdor R, Lam C, Movahed MR. The prevalence of Brugada ECG in adult patients in a large university hospital in the western United States. Am Heart Hosp J. 2008;6(1):48–50
   PubMedGoogle Scholar
• . Alings M, Wilde A. “Brugada” syndrome: clinical data and suggested pathophysiological mechanism. Circulation. 1999;99(5):666–673
   PubMed Web of Science ®Google Scholar
• . Chen Q, Kirsch GE, Zhang D, . Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392(6673):293–296
   PubMed Web of Science ®Google Scholar
• . London B, Michalec M, Mehdi H, . Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation. 2007;116(20):2260–2268
   PubMed Web of Science ®Google Scholar
• . Takimoto K, Li D, Nerbonne JM, Levitan ES. Distribution, splicing and glucocorticoid-induced expression of cardiac alpha 1C and alpha 1D voltage-gated Ca2+ channel mRNAs. J Mol Cell Cardiol. 1997;29(11):3035–3042
   PubMed Web of Science ®Google Scholar
• . Van Petegem F, Clark KA, Chatelain FC, Minor DL Jr. Structure of a complex between a voltage-gated calcium channel beta-subunit and an alpha-subunit domain. Nature. 2004;429(6992):671–675
   PubMed Web of Science ®Google Scholar
• . Watanabe H, Koopmann TT, Le Scouarnec S, . Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest. 2008;118(6):2260–2268
   PubMed Web of Science ®Google Scholar
• . Meadows LS, Isom LL. Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes. Cardiovasc Res. 2005;67(3):448–458
   PubMed Web of Science ®Google Scholar
• . Abbott GW, Sesti F, Splawski I, . MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999;97(2):175–187
   PubMed Web of Science ®Google Scholar
• . Antzelevitch C. Ion channels and ventricular arrhythmias: cellular and ionic mechanisms underlying the Brugada syndrome. Curr Opin Cardiol. 1999;14(3):274–279
   PubMed Web of Science ®Google Scholar
• . Nagase S, Kusano KF, Morita H, . Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. J Am Coll Cardiol. 2002;39:1992–1995
   PubMed Web of Science ®Google Scholar
• . Martin CA, Zhang Y, Grace AA, Huang CL. Increased right ventricular repolarization gradients promote arrhythmogenesis in a murine model of Brugada syndrome. J Cardiovasc Electrophysiol. 2010;21:1153–1159
   PubMed Web of Science ®Google Scholar
• . Matthews GD, Martin CA, Grace AA, Zhang Y, Huang CL. Regional variations in action potential alternans in isolated murine Scn5a(+/−) hearts during dynamic pacing. Acta Physiol (Oxf). 2010;200(2):129–146
   PubMed Web of Science ®Google Scholar
• . Vincent GM. Long QT syndrome. Cardiol Clin. 2000;18(2):309–325
   PubMedGoogle Scholar
• . January CT, Riddle JM. Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current. Circ Res. 1989;64(5):977–990
   PubMed Web of Science ®Google Scholar
• . Napolitano C, Priori SG, Schwartz PJ, . Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA. 2005;294(23):2975–2980
   PubMed Web of Science ®Google Scholar
• . Liu N, Ruan Y, Priori SG. Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis. 2008;51(1):23–30
   PubMed Web of Science ®Google Scholar
• . Swan H, Piippo K, Viitasalo M, . Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol. 1999;34(7):2035–2042
   PubMed Web of Science ®Google Scholar
• . Priori SG, Napolitano C, Tiso N, . Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103(2):196–200
   PubMed Web of Science ®Google Scholar
• . Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J Cell Physiol. 2002;190(1):1–6
   PubMed Web of Science ®Google Scholar
• . Lahat H, Eldar M, Levy-Nissenbaum E, . Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1 p13–21. Circulation. 2001;103(23):2822–2827
   PubMed Web of Science ®Google Scholar
• . Priori SG, Napolitano C, Memmi M, . Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106(1):69–74
   PubMed Web of Science ®Google Scholar
• . Mohler PJ, Splawski I, Napolitano C, . A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A. 2004;101(24):9137–9142
   PubMed Web of Science ®Google Scholar
• . Bhuiyan ZA, Hamdan MA, Shamsi ET, . A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22. J Cardiovasc Electrophysiol. 2007;18(10):1060–1066
   PubMed Web of Science ®Google Scholar
• . Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91(5):1512–1519
   PubMed Web of Science ®Google Scholar
• . Jiang D, Wang R, Xiao B, . Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res. 2005;97(11):1173–1181
   PubMed Web of Science ®Google Scholar
• . Lehnart SE, Wehrens XH, Laitinen PJ, . Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation. 2004;109(25):3208–3214
   PubMed Web of Science ®Google Scholar
• . Liu N, Colombi B, Memmi M, . Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res. 2006;99(3):292–298
   PubMed Web of Science ®Google Scholar
• . Knollmann BC, Chopra N, Hlaing T, . Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2006;116(9):2510–2520
   PubMed Web of Science ®Google Scholar
• . Antzelevitch C, Brugada P, Brugada J, Brugada R. Brugada syndrome: from cell to bedside. Curr Probl Cardiol. 2005;30(1):9–54
   PubMed Web of Science ®Google Scholar
• . Morita H, Morita ST, Nagase S, . Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol. 2003;42(9):1624–1631
   PubMed Web of Science ®Google Scholar
• . Itoh H, Shimizu M, Ino H, ; Hokuriku Brugada Study Group. Arrhythmias in patients with Brugada-type electrocardiographic findings. Jpn Circ J. 2001;65(5):483–486
   PubMedGoogle Scholar
• . Amin AS, de Groot EA, Ruijter JM, Wilde AA, Tan HL. Exercise-induced ECG changes in Brugada syndrome. Circ Arrhythm Electrophysiol. 2009;2(5):531–539
   PubMed Web of Science ®Google Scholar
• . Wilde AA, Antzelevitch C, Borggrefe M, . Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation. 2002;106(19):2514–2519
   PubMed Web of Science ®Google Scholar
• . Antzelevitch C, Brugada R. Fever and Brugada syndrome. Pacing Clin Electrophysiol. 2002;25(11):1537–1539
   PubMed Web of Science ®Google Scholar
• . Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 1996;27(5):1061–1070
   PubMed Web of Science ®Google Scholar
• . Hedley PL, Jorgensen P, Schlamowitz S, . The genetic basis of Brugada syndrome: a mutation update. Hum Mutat. 2009;30(9):1256–1266
   PubMed Web of Science ®Google Scholar
• . Srivathsan K, Lester SJ, Appleton CP, Scott LR, Munger TM. Ventricular tachycardia in the absence of structural heart disease. Indian Pacing Electrophysiol J. 2005;5(2):106–121
   PubMedGoogle Scholar
• . Roden DM, Anderson ME. The pause that refreshes, or does it? Mechanisms in torsades de pointes. Heart. 2000;84(3):235–237
   PubMed Web of Science ®Google Scholar
• . Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88(2):782–784
   PubMed Web of Science ®Google Scholar
• . Vincent GM, Timothy K, Fox J, Zhang L. The inherited long QT syndrome: from ion channel to bedside. Cardiol Rev. 1999;7(1):44–55
   PubMedGoogle Scholar
• . Schwartz PJ, Priori SG, Spazzolini C, . Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103(1):89–95
   PubMed Web of Science ®Google Scholar
• . Bai R, Napolitano C, Bloise R, Monteforte N, Priori SG. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ Arrhythm Electrophysiol. 2009;2(1):6–15
   PubMed Web of Science ®Google Scholar
• . Sacher F, Probst V, Iesaka Y, . Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation. 2006;114(22):2317–2324
   PubMed Web of Science ®Google Scholar
• . Brugada P, Brugada R, Brugada J. Sudden death in patients and relatives with the syndrome of right bundle branch block, ST segment elevation in the precordial leads V(1)to V(3)and sudden death. Eur Heart J. 2000;21(4):321–326
   PubMed Web of Science ®Google Scholar
• . Priori SG, Napolitano C, Gasparini M, . Natural history of Brugada syndrome: insights for risk stratification and management. Circulation. 2002;105(11):1342–1347
   PubMed Web of Science ®Google Scholar
• . Eckardt L, Kirchhof P, Schulze-Bahr E, . Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. Eur Heart J. 2002;23(17):1394–1401
   PubMed Web of Science ®Google Scholar
• . Antzelevitch C, Brugada P, Borggrefe M, . Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111(5):659–670
   PubMed Web of Science ®Google Scholar
• . Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation. 2004;110(13):1731–1737
   PubMed Web of Science ®Google Scholar
• . Viskin S, Wilde AA, Tan HL, Antzelevitch C, Shimizu W, Belhassen B. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry. Heart Rhythm. 2009;6(3):401–404
   PubMed Web of Science ®Google Scholar
• . Le Marec H, Probst V. BRD 06/2-D (Quidam) Evaluation of the Interest of Oral Hydroquinidine Administration to Treat Patients With Brugada Syndrome, High Cardiac Arrhythmic Risk and Implanted With an Implantable Cardioverter Defibrillator (NCT00927732). ClinicalTrials. gov. 2009. Accessed February 7, 2011
   Google Scholar
• . Postema PG, Wolpert C, Amin AS, . Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm. 2009;6(9): 1335–1341
   PubMed Web of Science ®Google Scholar
• . Zareba W, Moss AJ, Schwartz PJ, . Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339(14):960–965
   PubMed Web of Science ®Google Scholar
• . Compton SJ, Lux RL, Ramsey MR, . Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation. 1996;94(5):1018–1022
   PubMed Web of Science ®Google Scholar
• . Moss AJ, Zareba W, Hall WJ, . Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101(6):616–623
   PubMed Web of Science ®Google Scholar
• . Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol. 2003;14(4):337–341
   PubMed Web of Science ®Google Scholar
• . Goldenberg I, Moss AJ, Zareba W, . Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol. 2006;17:1161–1168
   PubMed Web of Science ®Google Scholar
• . Goldenberg I, Moss AJ, Peterson DR, . Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation. 2008;117(17):2184–2191
   PubMed Web of Science ®Google Scholar
• . Goldenberg I, Moss AJ. Long QT syndrome. J Am Coll Cardiol. 2008;51(24):2291–2300
   PubMed Web of Science ®Google Scholar
• . Ruan Y, Denegri M, Liu N, . Trafficking defects and gating abnormalities of a novel SCN5 A mutation question gene-specific therapy in long QT syndrome type 3. Circ Res. 2010;106(8):1374–1383
   PubMed Web of Science ®Google Scholar
• . Nakajima T, Kaneko Y, Taniguchi Y, . The mechanism of catecholaminergic polymorphic ventricular tachycardia may be triggered activity due to delayed afterdepolarization. Eur Heart J. 1997;18(3):530–531
   PubMed Web of Science ®Google Scholar
• . Sumitomo N, Harada K, Nagashima M, . Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart. 2003;89(1):66–70
   PubMed Web of Science ®Google Scholar
• . Swan H, Laitinen P, Kontula K, Toivonen L. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J Cardiovasc Electrophysiol. 2005;16(2):162–166
   PubMed Web of Science ®Google Scholar
• . Rosso R, Kalman JM, Rogowski O, . Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2007;4(9):1149–1154
   PubMed Web of Science ®Google Scholar
• . Watanabe H, Chopra N, Laver D, . Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med. 2009;15(4):380–383
   PubMed Web of Science ®Google Scholar
• . Wilde AA, Bhuiyan ZA, Crotti L, . Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358(19):2024–2029
   PubMed Web of Science ®Google Scholar
• . Gaita F, Giustetto C, Bianchi F, . Short QT syndrome: a familial cause of sudden death. Circulation. 2003;108(8):965–970
   PubMed Web of Science ®Google Scholar
• . Brugada R, Hong K, Dumaine R, . Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation. 2004;109(1):30–35
   PubMed Web of Science ®Google Scholar
• . Bellocq C, van Ginneken AC, Bezzina CR, . Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation. 2004;109(20):2394–2397
   PubMed Web of Science ®Google Scholar
• . Priori SG, Pandit SV, Rivolta I, . A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res. 2005;96(7):800–807
   PubMed Web of Science ®Google Scholar
• . Antzelevitch C, Pollevick GD, Cordeiro JM, . Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115(4):442–449
   PubMed Web of Science ®Google Scholar
• . Gaita F, Giustetto C, Bianchi F, . Short QT syndrome: pharmacological treatment. J Am Coll Cardiol. 2004;43:1494–1499
   PubMed Web of Science ®Google Scholar
• . Haissaguerre M, Derval N, Sacher F, . Sudden cardiac arrest associated with early repolarization. N Engl J Med. 2008;358:2016–2023
   PubMed Web of Science ®Google Scholar
• . Mehta M, Jain AC, Mehta A. Early repolarization. Clin Cardiol. 1999;22:59–65
   PubMed Web of Science ®Google Scholar
• . Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation. 1996;93(2):372–379
   PubMed Web of Science ®Google Scholar
• . Burashnikov E, Pfeiffer R, Barajas-Martinez H, . Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm. 2010;7(12):1872–1882
   PubMed Web of Science ®Google Scholar
• . Haissaguerre M, Chatel S, Sacher F, . Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol. 2009;20(1):93–98
   PubMed Web of Science ®Google Scholar
• . Tikkanen JT, Anttonen O, Junttila MJ, . Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med. 2009;361(26):2529–2537
   PubMed Web of Science ®Google Scholar
• . Nam GB, Ko KH, Kim J, . Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome. Eur Heart J. 2010;31(3):330–339
   PubMed Web of Science ®Google Scholar
• . Merchant FM, Noseworthy PA, Weiner RB, Singh SM, Ruskin JN, Reddy VY. Ability of terminal QRS notching to distinguish benign from malignant electrocardiographic forms of early repolarization. Am J Cardiol. 2009;104(10):1402–1406
   PubMed Web of Science ®Google Scholar
• . Schott JJ, Alshinawi C, Kyndt F, . Cardiac conduction defects associate with mutations in SCN5 A. Nat Genet. 1999;23(1):20–21
   PubMed Web of Science ®Google Scholar
• . Grant AO, Carboni MP, Neplioueva V, . Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest. 2002;110(8):1201–1209
   PubMed Web of Science ®Google Scholar
• . Brugada J, Brugada P, Brugada R. The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death–the Brugada syndrome. Europace. 1999;1(3):156–166
   PubMed Web of Science ®Google Scholar
• . Salama G, London B. Mouse models of long QT syndrome. J Physiol. 2007;578(pt 1):43–53
   PubMed Web of Science ®Google Scholar